{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T19:41:43Z","timestamp":1792784503039,"version":"4.5.0"},"reference-count":48,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2019,5,30]],"date-time":"2019-05-30T00:00:00Z","timestamp":1559174400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"},{"start":{"date-parts":[[2019,5,30]],"date-time":"2019-05-30T00:00:00Z","timestamp":1559174400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"}],"funder":[{"DOI":"10.13039\/100010878","name":"AbbVie Biotherapeutics","doi-asserted-by":"publisher","award":["IMM 09- 0054"],"award-info":[{"award-number":["IMM 09- 0054"]}],"id":[{"id":"10.13039\/100010878","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Arthritis Foundation WA","award":["unrestricted grant"],"award-info":[{"award-number":["unrestricted grant"]}],"id":[{"id":"https:\/\/ror.org\/04zk9fe75","id-type":"ROR","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Rheumatol Ther"],"published-print":{"date-parts":[[2019,9,1]]},"DOI":"10.1007\/s40744-019-0161-7","type":"journal-article","created":{"date-parts":[[2019,5,30]],"date-time":"2019-05-30T10:03:01Z","timestamp":1559210581000},"page":"369-378","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":12,"title":["Disease Activity and Patient-Reported Health Measures in Relation to Cytokine Levels in Ankylosing Spondylitis"],"prefix":"10.1007","volume":"6","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2833-7997","authenticated-orcid":false,"given":"Johannes C.","family":"Nossent","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sylvia","family":"Sagen-Johnsen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gunnstein","family":"Bakland","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,5,30]]},"reference":[{"issue":"6","key":"161_CR1","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1038\/nrrheum.2017.56","volume":"13","author":"V Ranganathan","year":"2017","unstructured":"Ranganathan V, Gracey E, Brown MA, Inman RD, Haroon N. Pathogenesis of ankylosing spondylitis\u2014recent advances and future directions. Nat Rev Rheumatol. 2017;13(6):359\u201367.","journal-title":"Nat Rev Rheumatol"},{"issue":"6","key":"161_CR2","doi-asserted-by":"publisher","first-page":"953","DOI":"10.1007\/s10067-006-0403-2","volume":"26","author":"CH Chen","year":"2007","unstructured":"Chen CH, Lin KC, Chen HA, Liao HT, Liang TH, Wang HP, et al. Association of acute anterior uveitis with disease activity, functional ability and physical mobility in patients with ankylosing spondylitis: a cross-sectional study of Chinese patients in Taiwan. Clin Rheumatol. 2007;26(6):953\u20137.","journal-title":"Clin Rheumatol"},{"issue":"3","key":"161_CR3","doi-asserted-by":"publisher","first-page":"447","DOI":"10.1007\/s10067-011-1854-7","volume":"31","author":"FM Pimentel-Santos","year":"2012","unstructured":"Pimentel-Santos FM, Mourao AF, Ribeiro C, Costa J, Santos H, Barcelos A, et al. Spectrum of ankylosing spondylitis in Portugal. Development of BASDAI, BASFI, BASMI and mSASSS reference centile charts. Clin Rheumatol. 2012;31(3):447\u201354.","journal-title":"Clin Rheumatol."},{"issue":"4","key":"161_CR4","first-page":"740","volume":"22","author":"Calin A The","year":"1995","unstructured":"The Calin A, Lecture Dunlop-Dottridge. Ankylosing spondylitis: defining disease status and the relationship between radiology, metrology, disease activity, function, and outcome. J Rheumatol. 1995;22(4):740\u20134.","journal-title":"J Rheumatol."},{"issue":"3","key":"161_CR5","doi-asserted-by":"publisher","first-page":"717","DOI":"10.1002\/art.24483","volume":"60","author":"M Rudwaleit","year":"2009","unstructured":"Rudwaleit M, Haibel H, Baraliakos X, Listing J, Marker-Hermann E, Zeidler H, et al. The early disease stage in axial spondyloarthritis: results from the German Spondyloarthritis Inception Cohort. Arthritis Rheum. 2009;60(3):717\u201327.","journal-title":"Arthritis Rheum"},{"issue":"1","key":"161_CR6","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1136\/annrheumdis-2017-211544","volume":"77","author":"C Molnar","year":"2018","unstructured":"Molnar C, Scherer A, Baraliakos X, de Hooge M, Micheroli R, Exer P, et al. TNF blockers inhibit spinal radiographic progression in ankylosing spondylitis by reducing disease activity: results from the Swiss Clinical Quality Management cohort. Ann Rheum Dis. 2018;77(1):63\u20139.","journal-title":"Ann Rheum Dis"},{"issue":"2","key":"161_CR7","doi-asserted-by":"publisher","first-page":"159","DOI":"10.2174\/187152812800392805","volume":"11","author":"E Toussirot","year":"2012","unstructured":"Toussirot E. The IL23\/Th17 pathway as a therapeutic target in chronic inflammatory diseases. Inflamm Allergy Drug Targ. 2012;11(2):159\u201368.","journal-title":"Inflamm Allergy Drug Targ"},{"issue":"8","key":"161_CR8","doi-asserted-by":"publisher","first-page":"1378","DOI":"10.1093\/rheumatology\/kes026","volume":"51","author":"X Baraliakos","year":"2012","unstructured":"Baraliakos X, van den Berg R, Braun J, van der Heijde D. Update of the literature review on treatment with biologics as a basis for the first update of the ASAS\/EULAR management recommendations of ankylosing spondylitis. Rheumatology. 2012;51(8):1378\u201387.","journal-title":"Rheumatology"},{"issue":"4","key":"161_CR9","doi-asserted-by":"publisher","first-page":"499","DOI":"10.1002\/art.1780380407","volume":"38","author":"J Braun","year":"1995","unstructured":"Braun J, Bollow M, Neure L, Seipelt E, Seyrekbasan F, Herbst H, et al. Use of immunohistologic and in situ hybridization techniques in the examination of sacroiliac joint biopsy specimens from patients with ankylosing spondylitis. Arthritis Rheum. 1995;38(4):499\u2013505.","journal-title":"Arthritis Rheum"},{"issue":"1","key":"161_CR10","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1016\/j.molimm.2013.06.013","volume":"57","author":"PC Robinson","year":"2014","unstructured":"Robinson PC, Brown MA. Genetics of ankylosing spondylitis. Mol Immunol. 2014;57(1):2\u201311.","journal-title":"Mol Immunol"},{"issue":"7","key":"161_CR11","doi-asserted-by":"publisher","first-page":"1747","DOI":"10.1002\/art.37976","volume":"65","author":"SI Davidson","year":"2013","unstructured":"Davidson SI, Jiang L, Cortes A, Wu X, Glazov EA, Donskoi M, et al. Brief report: high-throughput sequencing of IL23R reveals a low-frequency, nonsynonymous single-nucleotide polymorphism that is associated with ankylosing spondylitis in a Han Chinese population. Arthritis Rheum. 2013;65(7):1747\u201352.","journal-title":"Arthritis Rheum"},{"issue":"4","key":"161_CR12","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1097\/BOR.0000000000000069","volume":"26","author":"N Yeremenko","year":"2014","unstructured":"Yeremenko N, Paramarta JE, Baeten D. The interleukin-23\/interleukin-17 immune axis as a promising new target in the treatment of spondyloarthritis. Curr Opin Rheumatol. 2014;26(4):361\u201370.","journal-title":"Curr Opin Rheumatol"},{"issue":"6","key":"161_CR13","doi-asserted-by":"publisher","first-page":"474","DOI":"10.3109\/03009742.2016.1150507","volume":"45","author":"JC Nossent","year":"2016","unstructured":"Nossent JC, Johnsen S, Bakland G. The influence of ERAP1 gene variants on clinical phenotype in ankylosing spondylitis. Scand J Rheumatol. 2016;45(6):474\u20139.","journal-title":"Scand J Rheumatol"},{"issue":"9","key":"161_CR14","doi-asserted-by":"publisher","first-page":"1907","DOI":"10.3899\/jrheum.100019","volume":"37","author":"N Haroon","year":"2010","unstructured":"Haroon N, Tsui FW, Chiu B, Tsui HW, Inman RD. Serum cytokine receptors in ankylosing spondylitis: relationship to inflammatory markers and endoplasmic reticulum aminopeptidase polymorphisms. J Rheumatol. 2010;37(9):1907\u201310.","journal-title":"J Rheumatol."},{"issue":"6","key":"161_CR15","doi-asserted-by":"publisher","first-page":"850","DOI":"10.1002\/art.21577","volume":"53","author":"G Bakland","year":"2005","unstructured":"Bakland G, Nossent HC, Gran JT. Incidence and prevalence of ankylosing spondylitis in northern Norway. Arthritis Rheum. 2005;53(6):850\u20135.","journal-title":"Arthritis Rheum"},{"issue":"7","key":"161_CR16","doi-asserted-by":"publisher","first-page":"1350","DOI":"10.1136\/annrheumdis-2012-202976","volume":"73","author":"C Fernandez-Espartero","year":"2014","unstructured":"Fernandez-Espartero C, de Miguel E, Loza E, Tomero E, Gobbo M, Descalzo MA, et al. Validity of the ankylosing spondylitis disease activity score (ASDAS) in patients with early spondyloarthritis from the Esperanza programme. Ann Rheum Dis. 2014;73(7):1350\u20135.","journal-title":"Ann Rheum Dis"},{"issue":"10","key":"161_CR17","doi-asserted-by":"publisher","first-page":"1539","DOI":"10.1136\/annrheumdis-2018-213184","volume":"77","author":"PM Machado","year":"2018","unstructured":"Machado PM, Landewe R, Heijde DV. Assessment of Spondylo. Arthritis international S Ankylosing Spondylitis Disease Activity Score (ASDAS): 2018 update of the nomenclature for disease activity states. Ann Rheum Dis. 2018;77(10):1539\u201340.","journal-title":"Ann Rheum Dis."},{"issue":"8","key":"161_CR18","doi-asserted-by":"publisher","first-page":"1675","DOI":"10.3899\/jrheum.131315","volume":"41","author":"JC Nossent","year":"2014","unstructured":"Nossent JC, Sagen-Johnsen S, Bakland G. Tumor necrosis factor-alpha promoter -308\/238 polymorphism association with less severe disease in ankylosing spondylitis is unrelated to serum TNF-alpha and does not predict TNF inhibitor response. J Rheumatol. 2014;41(8):1675\u201382.","journal-title":"J Rheumatol."},{"issue":"5","key":"161_CR19","doi-asserted-by":"publisher","first-page":"336","DOI":"10.1093\/rheumatology\/30.5.336","volume":"30","author":"JA Goodacre","year":"1991","unstructured":"Goodacre JA, Mander M, Dick WC. Patients with ankylosing spondylitis show individual patterns of variation in disease activity. Br J Rheumatol. 1991;30(5):336\u20138.","journal-title":"Br J Rheumatol"},{"key":"161_CR20","doi-asserted-by":"publisher","first-page":"163","DOI":"10.2147\/OARRR.S4490","volume":"1","author":"F Cantini","year":"2009","unstructured":"Cantini F, Nannini C, Niccoli L. Bioboosters in the treatment of rheumatic diseases: a comprehensive review of currently available biologics in patients with rheumatoid arthritis, ankylosing spondylitis and psoriatic arthritis. Open Access Rheumatol. 2009;1:163\u201378.","journal-title":"Open Access Rheumatol."},{"issue":"5","key":"161_CR21","doi-asserted-by":"publisher","first-page":"410","DOI":"10.1093\/rheumatology\/28.5.410","volume":"28","author":"MJ Davis","year":"1989","unstructured":"Davis MJ, Dawes PT, Beswick E, Lewin IV, Stanworth DR. Sulphasalazine therapy in ankylosing spondylitis: its effect on disease activity, immunoglobulin A and the complex immunoglobulin A-alpha-1-antitrypsin. Br J Rheumatol. 1989;28(5):410\u20133.","journal-title":"Br J Rheumatol"},{"issue":"4","key":"161_CR22","doi-asserted-by":"publisher","first-page":"579","DOI":"10.1007\/s11845-013-1054-3","volume":"183","author":"C Sullivan","year":"2014","unstructured":"Sullivan C, Quinn K, Harney S, Ryan JG. The use of anti-TNF therapy for ankylosing spondylitis in everyday rheumatology practice and the relationship to disease activity, work disability and diagnostic delay. Ir J Med Sci. 2014;183(4):579\u201384.","journal-title":"Ir J Med Sci"},{"issue":"5","key":"161_CR23","first-page":"908","volume":"24","author":"E Roussou","year":"1997","unstructured":"Roussou E, Kennedy LG, Garrett S, Calin A. Socioeconomic status in ankylosing spondylitis: relationship between occupation and disease activity. J Rheumatol. 1997;24(5):908\u201311.","journal-title":"J Rheumatol."},{"issue":"9","key":"161_CR24","doi-asserted-by":"publisher","first-page":"878","DOI":"10.1093\/rheumatology\/38.9.878","volume":"38","author":"A Calin","year":"1999","unstructured":"Calin A, Nakache JP, Gueguen A, Zeidler H, Mielants H, Dougados M. Defining disease activity in ankylosing spondylitis: is a combination of variables (Bath Ankylosing Spondylitis Disease Activity Index) an appropriate instrument? Rheumatology. 1999;38(9):878\u201382.","journal-title":"Rheumatology"},{"issue":"12","key":"161_CR25","doi-asserted-by":"publisher","first-page":"1811","DOI":"10.1136\/ard.2008.100826","volume":"68","author":"D van der Heijde","year":"2009","unstructured":"van der Heijde D, Lie E, Kvien TK, Sieper J, Van den Bosch F, Listing J, et al. ASDAS, a highly discriminatory ASAS-endorsed disease activity score in patients with ankylosing spondylitis. Ann Rheum Dis. 2009;68(12):1811\u20138.","journal-title":"Ann Rheum Dis"},{"issue":"6","key":"161_CR26","doi-asserted-by":"publisher","first-page":"1065","DOI":"10.1136\/ard.2009.111187","volume":"69","author":"SJ Pedersen","year":"2010","unstructured":"Pedersen SJ, Sorensen IJ, Hermann KG, Madsen OR, Tvede N, Hansen MS, et al. Responsiveness of the Ankylosing Spondylitis Disease Activity Score (ASDAS) and clinical and MRI measures of disease activity in a 1-year follow-up study of patients with axial spondyloarthritis treated with tumour necrosis factor alpha inhibitors. Ann Rheum Dis. 2010;69(6):1065\u201371.","journal-title":"Ann Rheum Dis"},{"key":"161_CR27","doi-asserted-by":"crossref","unstructured":"Viitanen JV, Kokko ML, Lehtinen K, Suni J, Kautiainen H. Correlation between mobility restrictions and radiologic changes in ankylosing spondylitis. Spine (Phila Pa 1976). 1995;20(4):492\u20136.","DOI":"10.1097\/00007632-199502001-00015"},{"issue":"8","key":"161_CR28","doi-asserted-by":"publisher","first-page":"1465","DOI":"10.1136\/ard.2009.124206","volume":"69","author":"P Machado","year":"2010","unstructured":"Machado P, Landewe R, Braun J, Hermann KG, Baker D, van der Heijde D. Both structural damage and inflammation of the spine contribute to impairment of spinal mobility in patients with ankylosing spondylitis. Ann Rheum Dis. 2010;69(8):1465\u201370.","journal-title":"Ann Rheum Dis"},{"issue":"1","key":"161_CR29","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1002\/acr.22400","volume":"67","author":"J Calvo-Gutierrez","year":"2015","unstructured":"Calvo-Gutierrez J, Garrido-Castro JL, Gil-Cabezas J, Gonzalez-Navas C, Ugalde PF, Carmona L, et al. Is spinal mobility in patients with spondylitis determined by age, structural damage, and inflammation? Arthritis Care Res. 2015;67(1):74\u20139.","journal-title":"Arthritis Care Res."},{"issue":"10","key":"161_CR30","doi-asserted-by":"publisher","first-page":"2881","DOI":"10.1007\/s10067-018-4195-y","volume":"37","author":"B Sundstrom","year":"2018","unstructured":"Sundstrom B, Ljung L, Wallberg-Jonsson S. Exercise habits and C-reactive protein may predict development of spinal immobility in patients with ankylosing spondylitis. Clin Rheumatol. 2018;37(10):2881\u20135.","journal-title":"Clin Rheumatol"},{"issue":"7","key":"161_CR31","doi-asserted-by":"publisher","first-page":"1511","DOI":"10.1007\/s10067-017-3654-1","volume":"36","author":"T Donisan","year":"2017","unstructured":"Donisan T, Bojinca VC, Dobrin MA, Balanescu DV, Predeteanu D, Bojinca M, et al. The relationship between disease activity, quality of life, and personality types in rheumatoid arthritis and ankylosing spondylitis patients. Clin Rheumatol. 2017;36(7):1511\u20139.","journal-title":"Clin Rheumatol"},{"issue":"11","key":"161_CR32","doi-asserted-by":"publisher","first-page":"3471","DOI":"10.1007\/s00296-011-2190-6","volume":"32","author":"Z Jajic","year":"2012","unstructured":"Jajic Z, Rajnpreht I, Kovacic N, Lukic IK, Velagic V, Grubisic F, et al. Which clinical variables have the most significant correlation with quality of life evaluated by SF-36 survey in Croatian cohort of patient with ankylosing spondylitis and psoriatic arthritis? Rheumatol Int. 2012;32(11):3471\u20139.","journal-title":"Rheumatol Int"},{"issue":"5","key":"161_CR33","doi-asserted-by":"publisher","first-page":"828","DOI":"10.1016\/j.semarthrit.2018.07.015","volume":"48","author":"B van der Slik","year":"2019","unstructured":"van der Slik B, Spoorenberg A, Wink F, Bos R, Bootsma H, Maas F, et al. Although female patients with ankylosing spondylitis score worse on disease activity than male patients and improvement in disease activity is comparable, male patients show more radiographic progression during treatment with TNF-alpha inhibitors. Semin Arthritis Rheum. 2019;48(5):828\u201333.","journal-title":"Semin Arthritis Rheum."},{"issue":"5","key":"161_CR34","doi-asserted-by":"publisher","first-page":"605","DOI":"10.1007\/s00296-009-1328-2","volume":"31","author":"O Ozdemir","year":"2011","unstructured":"Ozdemir O. Quality of life in patients with ankylosing spondylitis: relationships with spinal mobility, disease activity and functional status. Rheumatol Int. 2011;31(5):605\u201310.","journal-title":"Rheumatol Int"},{"issue":"3","key":"161_CR35","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1007\/s00296-017-3920-1","volume":"38","author":"OR Madsen","year":"2018","unstructured":"Madsen OR. Stability of fatigue, pain, patient global assessment and the Bath Ankylosing Spondylitis Functional Index (BASFI) in spondyloarthropathy patients with stable disease according to the Bath Ankylosing Spondylitis Disease Activity Index (BASDAI). Rheumatol Int. 2018;38(3):425\u201332.","journal-title":"Rheumatol Int"},{"issue":"1","key":"161_CR36","doi-asserted-by":"publisher","first-page":"62","DOI":"10.3899\/jrheum.160411","volume":"45","author":"LE Dean","year":"2018","unstructured":"Dean LE, Macfarlane GJ, Jones GT. Five potentially modifiable factors predict poor quality of life in ankylosing spondylitis: results from the Scotland Registry for ankylosing spondylitis. J Rheumatol. 2018;45(1):62\u20139.","journal-title":"J Rheumatol."},{"issue":"3","key":"161_CR37","doi-asserted-by":"publisher","first-page":"499","DOI":"10.3233\/BMR-169657","volume":"31","author":"S Sag","year":"2018","unstructured":"Sag S, Nas K, Sag MS, Tekeoglu I, Kamanli A. Relationship of work disability between the disease activity, depression and quality of life in patients with ankylosing spondylitis. J Back Musculoskelet Rehabil. 2018;31(3):499\u2013505.","journal-title":"J Back Musculoskelet Rehabil."},{"issue":"2","key":"161_CR38","first-page":"159","volume":"33","author":"TA Claushuis","year":"2015","unstructured":"Claushuis TA, de Vries MK, van der Weijden MA, Visman IM, Nurmohamed MT, Twisk JW, et al. C-reactive protein polymorphisms influence serum CRP-levels independent of disease activity in ankylosing spondylitis. Clin Exp Rheumatol. 2015;33(2):159\u201365.","journal-title":"Clin Exp Rheumatol"},{"issue":"1","key":"161_CR39","doi-asserted-by":"publisher","first-page":"e000153","DOI":"10.1136\/rmdopen-2015-000153","volume":"1","author":"S Ramiro","year":"2015","unstructured":"Ramiro S, Landewe R, van Tubergen A, Boonen A, Stolwijk C, Dougados M, et al. Lifestyle factors may modify the effect of disease activity on radiographic progression in patients with ankylosing spondylitis: a longitudinal analysis. RMD Open. 2015;1(1):e000153.","journal-title":"RMD Open."},{"issue":"4","key":"161_CR40","doi-asserted-by":"publisher","first-page":"984","DOI":"10.1016\/j.jaci.2016.06.033","volume":"138","author":"M Akdis","year":"2016","unstructured":"Akdis M, Aab A, Altunbulakli C, Azkur K, Costa RA, Crameri R, et al. Interleukins (from IL-1 to IL-38), interferons, transforming growth factor beta, and TNF-alpha: receptors, functions, and roles in diseases. J Allergy Clin Immunol. 2016;138(4):984\u20131010.","journal-title":"J Allergy Clin Immunol."},{"issue":"12","key":"161_CR41","doi-asserted-by":"publisher","first-page":"2124","DOI":"10.1136\/annrheumdis-2015-208902","volume":"75","author":"E Gracey","year":"2016","unstructured":"Gracey E, Qaiyum Z, Almaghlouth I, Lawson D, Karki S, Avvaru N, et al. IL-7 primes IL-17 in mucosal-associated invariant T (MAIT) cells, which contribute to the Th17-axis in ankylosing spondylitis. Ann Rheum Dis. 2016;75(12):2124\u201332.","journal-title":"Ann Rheum Dis"},{"issue":"7","key":"161_CR42","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1016\/j.jcma.2012.05.006","volume":"75","author":"WS Chen","year":"2012","unstructured":"Chen WS, Chang YS, Lin KC, Lai CC, Wang SH, Hsiao KH, et al. Association of serum interleukin-17 and interleukin-23 levels with disease activity in Chinese patients with ankylosing spondylitis. J Chin Med Assoc. 2012;75(7):303\u20138.","journal-title":"J Chin Med Assoc."},{"key":"161_CR43","doi-asserted-by":"publisher","first-page":"105","DOI":"10.2147\/TACG.S37325","volume":"7","author":"FW Tsui","year":"2014","unstructured":"Tsui FW, Tsui HW, Akram A, Haroon N, Inman RD. The genetic basis of ankylosing spondylitis: new insights into disease pathogenesis. Appl Clin Genet. 2014;7:105\u201315.","journal-title":"Appl Clin Genet."},{"issue":"3","key":"161_CR44","doi-asserted-by":"publisher","first-page":"542","DOI":"10.1080\/14397595.2017.1367076","volume":"28","author":"S Monti","year":"2018","unstructured":"Monti S, Todoerti M, Codullo V, Favalli EG, Biggioggero M, Becciolini A, et al. Prevalence of Ankylosing Spondylitis Disease Activity Score (ASDAS) inactive disease in a cohort of patients treated with TNF-alpha inhibitors. Mod Rheumatol. 2018;28(3):542\u20139.","journal-title":"Mod Rheumatol"},{"key":"161_CR45","first-page":"1","volume":"7","author":"M Kishimoto","year":"2018","unstructured":"Kishimoto M, Taniguchi A, Fujishige A, Kaneko S, Haemmerle S, Porter BO, et al. Efficacy and safety of secukinumab in Japanese patients with active ankylosing spondylitis: 24-week results from an open-label phase 3 study (measure 2-J). Mod Rheumatol. 2018;7:1\u201323.","journal-title":"Mod Rheumatol."},{"issue":"5","key":"161_CR46","doi-asserted-by":"publisher","first-page":"826","DOI":"10.1093\/rheumatology\/kev421","volume":"55","author":"BVJ Cuppen","year":"2015","unstructured":"Cuppen BVJ, Welsing PMJ, Sprengers JJ, Bijlsma JWJ, Marijnissen ACA, van Laar JM, et al. Personalized biological treatment for rheumatoid arthritis: a systematic review with a focus on clinical applicability. Rheumatology. 2015;55(5):826\u201339.","journal-title":"Rheumatology"},{"issue":"Suppl 1","key":"161_CR47","doi-asserted-by":"publisher","first-page":"e000054","DOI":"10.1136\/rmdopen-2015-000054","volume":"1","author":"V Rios Rodriguez","year":"2015","unstructured":"Rios Rodriguez V, Poddubnyy D. Old and new treatment targets in axial spondyloarthritis. RMD open. 2015;1(Suppl 1):e000054.","journal-title":"RMD open."},{"issue":"4","key":"161_CR48","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1111\/j.1399-0004.1982.tb01428.x","volume":"22","author":"P Moller","year":"1982","unstructured":"Moller P, Vinje O, Kass E, Berg K. The distribution of clinical findings in Bechterew\u2019s syndrome (ankylosing spondylitis) suggests distinct genetic subgroups. Clin Genet. 1982;22(4):151\u20139.","journal-title":"Clin Genet"}],"container-title":["Rheumatology and Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40744-019-0161-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s40744-019-0161-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40744-019-0161-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,5,8]],"date-time":"2024-05-08T13:20:05Z","timestamp":1715174405000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s40744-019-0161-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,5,30]]},"references-count":48,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2019,9,1]]}},"alternative-id":["161"],"URL":"https:\/\/doi.org\/10.1007\/s40744-019-0161-7","relation":{},"ISSN":["2198-6576","2198-6584"],"issn-type":[{"value":"2198-6576","type":"print"},{"value":"2198-6584","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,5,30]]},"assertion":[{"value":"4 March 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 May 2019","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}]}}